ARC:PIL This is an aggressive 3x-leveraged ETF offering top-5 exposure to a diverse mix of defensive value, hyper-growth mid-caps, and clinical-stage biotechnology plays.
Add to watchlist.
You're not a member! Trial today
Posted on | by Leon Hinde
